Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC)
This study has been completed.
Sponsor:
Zeria Pharmaceutical
Information provided by:
Zeria Pharmaceutical
ClinicalTrials.gov Identifier:
NCT00731445
First received: August 8, 2008
Last updated: June 29, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |